GXO Logistics Inc vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? GXO Logistics Inc trades at $45.88 (market cap $5.26B), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.03B). The key difference: GXO Logistics Inc is the larger of the two by market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, GXO Logistics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GXO Logistics Inc for 29 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.
| GXO | INDV | |
|---|---|---|
Market Cap | $5.26B | $4.03B |
Volume | 1,088,297 | 2,781,171 |
Sector | Industrials | Health |
52-Week High | $65.59 | $41.83 |
52-Week Low | $44.17 | $24.09 |
Typical Hold Time | 29 Days | 0 Days |
Enterprise Value | $10.61B | $4.32B |
Signals from Pluang's Aura AI — not financial advice
GXO trades at $46.50, down slightly by 0.21% on the day, with a neutral technical signal. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue growth is modest, with 2026 revenue projected at $13.6B and net income improving to $131M. Positive news includes new strategic partnerships and leadership appointments aimed at growth.
The outlook is supported by a strong analyst consensus with 16 buy ratings and a $65.86 price target, implying significant upside. Key risks include margin pressures and competitive industry dynamics. Cash flow trends are positive, with net cash flow rising to $566M in 2026, supporting operational investments.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
GXO is the world's largest pure-play contract logistics provider. It offers cutting-edge supply chain solutions, including automated warehousing and fulfillment, for global blue-chip companies.
Read more on GXO →Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →